BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 1, 2013
View Archived Issues
Pfizer discloses fourth-quarter and full-year 2012 results
Read More
Adamed presents new series of agents for CNS disorders
Read More
Vaxart describes avian influenza adenovirus-based vaccine and double-stranded RNA adjuvant
Read More
Researchers engineer synthetic biomarkers for urinary monitoring
Read More
Chugai provides update on pipeline along with 2012 financial results
Read More
Glucose lowered equally with mitoglitazone and pioglitazone in diabetes trial
Read More
New STEP inhibitors designed at Otsuka
Read More
New recombinant head shock proteins developed at Alternative Innovative Technologies
Read More
New MAbs described by Oxford BioTherapeutics
Read More
New anti-properdin antibodies developed at the University of Pennsylvania
Read More
Polymorphism in the ANGPT1 gene as predictor of increased mortality in septic shock patients
Read More
Svelte Medical Systems treats first patient in the DIRECT II stent study
Read More
Study of tasimelteon in MDD fails to meet endpoint
Read More
Italian hospital to conduct phase I/II trial of DPX-0907
Read More
Celsion reports results from the phase III HEAT study of ThermoDox
Read More
Ezose Sciences enters glycomics research agreement
Read More
Phylogica receives milestone payment under collaboration with Janssen Biotech
Read More
First patient enrolled in phase III tivantinib trial
Read More
Pharmaxis provides update on Bronchitol
Read More
A novel synthetic cofactor of glyoxalase prevents long-term cognitive impairment in vivo
Read More
Galectin Therapeutics files IND for phase I studies of GR-MD-02
Read More
Targovax includes first patient in phase I/II TG-01 study
Read More
Mobile ELISA device allows disease testing and transmission of results
Read More
OncoEthix studies OTX-015 in patients with hematologic malignancies
Read More
Committee recommends completion of phase IIb tamibarotene trial
Read More
FDA issues approval letter regarding expanded Corifact indication
Read More
